Ageing markers

Biomarker

2 papers2 findings

  • Animals1
  • Model organisms1

Interventions

2

GNF-5837

downin animals1

1 study
  1. GNF-5837 decreases ageing markers.

    “GNF-5837 reduced the expression of ageing markers by upregulating GPX7”

    Animals

    GNF-5837 alleviates intervertebral disc ageing by upregulating glutathione peroxidase 7

    International journal of immunopathology and pharmacology6 Jun 2025

More on GNF-5837

Intermittent time-restricted feeding

downin flies1

1 study
  1. Intermittent time-restricted feeding decreases ageing markers in flies.

    “delayed the onset of ageing markers in the muscles and gut”

    Model organismsmuscles and gut

    Circadian autophagy drives iTRF-mediated longevity

    Nature29 Sep 2021

More on Intermittent time-restricted feeding

Latest

Nov 2025: 7Dec 2025: 14Jan 2026: 14Feb 2026: 11Mar 2026: 12Apr 2026: 8May 2026: 9Jun 2026: 11Jul 2026: 10Aug 2026: 7Sep 2026: 11Oct 2026: 6120 in 12 months
Biochimica et Biophysica Acta Molecular Basis of Disease

Low cell-attachment protein levels linked to heart aging in mice

Mice with one working copy of the protein’s gene had enlarged, scarred hearts and poorer pumping, resembling changes in aged mice.Mice with one working copy of the protein’s gene had enlarged, scarred hearts and poorer pumping, resembling changes in aged mice.

Experiments in aged and Cdon+/- miceMechanisms

Limit: Whether changing CDON affects heart aging in people remains untested

Research Square

Estimated brain-age gap rises by three years in pregnancy

Brain-age gap estimates rose by about three years during pregnancy and fell below pre-conception levels by 16 months postpartum in a longitudinal study.Brain-age gap estimates rose by about three years during pregnancy and fell below pre-conception levels by 16 months postpartum in a longitudinal study.

Preprint: cohort study of 340 peoplePopulations
medRxiv

Hormone therapy linked to lower breast cancer mortality

Compared with never-users, hormone therapy ever-users had adjusted hazard ratios, which compare event rates over time, of 0.72 for breast cancer death and 1.17 for…Compared with never-users, hormone therapy ever-users had adjusted hazard ratios, which compare event rates over time, of 0.72 for breast cancer death and 1.17 for diagnosis.

Preprint: cohort study of 78,209 peopleBreast cancer